PA
DTIL icon

Parallel Advisors’s Precision BioSciences DTIL Stock Holding History

Parallel Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2
Closed -$1K – 3135
2021
Q3 		$1K Sell
2
-36
-95% -$12.2K ﹤0.01% 2842
2021
Q2 		$14K Buy
38
+5
+15% +$1.5K ﹤0.01% 1850
2021
Q1 		$10K Hold
33
– – ﹤0.01% 1915
2020
Q4 		$8K Hold
33
– – ﹤0.01% 1870
2020
Q3 		$6K Hold
33
– – ﹤0.01% 1940
2020
Q2 		$8K Hold
33
– – ﹤0.01% 1795
2020
Q1 		$6K Hold
33
– – ﹤0.01% 1823
2019
Q4 		$14K Hold
33
– – ﹤0.01% 1571
2019
Q3 		$8K Sell
33
-247
-88% -$80.4K ﹤0.01% 1750
2019
Q2 		$111K Buy
+280
New +$113K 0.01% 638

Other funds holding DTIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Parallel Advisors's DTIL Position: Q4 2021 in Review

Parallel Advisors sold out of Precision BioSciences (DTIL) in Q4 2021, closing a stake of 2 shares — an estimated $1K sold.

Parallel Advisors first reported a position in DTIL in Q2 2019 and held it in 10 quarters. The position peaked at $111K in Q2 2019. 134 funds tracked by Wall St. Rank hold DTIL as of Q4 2021.

  • Parallel Advisors reported no remaining Precision BioSciences position as of Q4 2021 after selling out during the quarter.
  • Parallel Advisors sold 2 Precision BioSciences shares in Q4 2021, an estimated $1K.
  • Parallel Advisors first reported a position in Precision BioSciences in Q2 2019 and held it in 10 quarters.
  • Parallel Advisors's Precision BioSciences position peaked at $111K in Q2 2019.
  • 134 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2021.

Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.